Cystic Fibrosis Foundation released the following clinical trial alert in June 2020.
June 16, 2020
Description: This study will look at the safety and effectiveness of the drug MS1819 in enteric capsules as a pancreatic enzyme replacement therapy (PERT).
Age: 18 Years and Older
Mutation: No Mutation Requirement
Fev1% Predicted: 30% or greater
Number of Visits: 10
Length of Participation: 8 weeks
ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT04375878